Available soon : BIOMIMESYS® plates for 3D cell culture!

HCS Pharma, expert in cellular imaging & in vitro assay development for High Content Screening (HCS) & Analysis (HCA) has just acquired BIOMIMESYS® Technology, a biomimetic hydrogel scaffold based on biofunctionalized hyaluronic acid with extracellular matrix components for 3D cell culture.

If you have already used BIOMIMESYS® products, be aware that they will be available again in early 2018! If you do not know yet this technology, please let us know your interest.

Using BIOMIMESYS® Technology, HCS Pharma will also provide its expertise in HCS/HCA to evaluate the efficacy, mode of action, and safety of your therapeutic molecules on 3D cell models.

Ask us for a TC to know more about our services and products.

BIOMIMESYS® Plates’ assets:

• Natural biofunctionnalized scaffold
• Ready-to-use and easy to handle for highly reproducible experiments
• Compatible with HTS & HCS
• Use also for long term cultures & in vivo transplantation
• Ease of cell retrieval, PCR & WB analysis